A novel herbal preparation desensitizes mesenteric afferents to bradykinin in the rat small intestine

Neurogastroenterology and Motility

Volumn 21, Issue 4, 2009, Pages 467-476

  Mueller, M H ^a   Gong, Q ^a,b   Kelber, O ^c   Kasparek, M S ^a,b   Sibaev, A ^a   Mansmann, U ^d   Yuce, B ^d   Li, Y Y ^b   Storr, M ^d   Kreis, M E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TONGJI UNIVERSITY   (China)

^c Steigerwald Arzneimittelwerk GmbH   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Afferent; Herbal medicine; Jejunum; Phytomedicine; Visceral hypersensitivity

Indexed keywords

BRADYKININ; HERBACEOUS AGENT; SEROTONIN; STW 5 II; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; INTESTINE DISTENSION; INTESTINE INNERVATION; INTESTINE PRESSURE; JEJUNUM; MALE; MESENTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE;

ACTION POTENTIALS; ANIMALS; BRADYKININ; ELECTROPHYSIOLOGY; INTESTINE, SMALL; MALE; MESENTERY; PAIN THRESHOLD; PLANT PREPARATIONS; RATS; RATS, WISTAR; VISCERAL AFFERENTS;

EID: 62449105966     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01232.x     Document Type: Article

References (42)

1. Fass R, Dickman R. Non-cardiac chest pain: an update. Neurogastroenterol Motil 2006 18 : 408 17.
2. Talley NJ. Irritable bowel syndrome. Intern Med J 2006 36 : 724 8.
3. Quigley EM, Bytzer P, Jones R, Mearin F. Irritable bowel syndrome: the burden and unmet needs in Europe. Dig Liver Dis 2006 38 : 717 23.
4. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in irritable bowel syndrome. Gut 1973 1 : 125 32.
5. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia. Am J Gastroenterol 2001 121 : 526 35.
6. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998 115 : 1246 352.
7. Cole JA, Cook SF, Sands BE, Ajene AN, Miller DP, Walker AM. Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol 2004 99 : 486 91.
8. Grundy D, McLean P, Stead R. Impact of 5-HT3 receptor blockade on colonic haemodynamic responses to ischaemia and reperfusion in the rat. Neurogastroenterol Motil 2007 19 : 607 16.
9. Madisch A, Holtmann G, Plein K, Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004 19 : 271 9.
10. Rösch W, Vinson B, Sassin I. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z Gastroenterol 2002 40 : 401 8.
11. v. Arnim U, Peitz U, Vinson B, Gundermann KJ, Malfertheiner P. STW 5, a phytopharmacon for patients with functional dyspepsia. Results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol 2007 102 : 1268 75.
12. Rösch W, Liebregts T, Gundermann KJ, Vinson B, Holtmann G. Phytotherapy for functional dyspepsia: A review of the clinical evidence for the herbal preparation STW 5. Phytomedicine 2006 13 (Suppl. 5 114 21.
13. Liu CY, Müller MH, Glatzle J et al. The herbal preparation STW 5 (Iberogast®) desensitizes intestinal afferents in the rat small intestine. Neurogastroenterology 2004 16 : 759 64.
14. Pinheiro JC, Bates DM. Mixed Effects Models in S and S-Plus. New York : Springer, 2000.
15. Kelly SJ, Bonthius DJ, West JR. Developmental changes in alcohol pharmacokinetics in rats. Alcohol Clin Exp Res 1987 11 : 281 6.
16. Wood JN, Docherty R. Chemical activators of sensory neurons. Annu Rev Physiol 1997 59 : 457 82.
17. 1 receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules. J Exp Med 2000 192 : 367 80.
18. Duchene J, Lecomte F, Ahmed S et al. A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5. J Immunol 2007 179 : 4849 56.
19. Bueno L, Fioramonti J, Garcia-Villar R. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. Am J Physiol Gastrointest Liver Physiol 2000 278 : G670 6.
20. Booth CE, Kirkup AJ, Hicks GA, Humphrey PP, Grundy D. Somatostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 2001 121 : 358 69.
21. Brundsden AM, Grundy D. Sensitization of visceral afferents to bradykinin in rat jejunum in vitro. J Physiol 1999 521 : 517 27.
22. Dunn PM, Rang HP. Bradykinin-induced depolarisation of primary afferent nerve terminals in the neonatal rat spinal cord in vitro. Br J Pharmacol 1990 100 : 656 60.
23. Maubach KA, Grundy D. The role of prostaglandins in the bradykinin-induced activation of serosal afferents of the rat jejunum in vitro. J Physiol (Lond) 1999 515 : 277 85.
24. Masferrer JL, Zweifel BS, Manning PT et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and non-ulcerogenic. Proc Natl Acad Sci 1994 91 : 3228 32.
25. Brierley SM, Jones RC 3rd., Xu L, Gebhart GF, Blackshaw LA. Activation of splanchnic and pelvic colonic afferents by bradykinin in mice. Neurogastroenterol Motil 2005 17 : 854 62.
26. Jaenig W, Morrison JFB. Functional properties of spinal visceral afferents supplying abdominal and pelvic organs with special emphasis on visceral nociception. In : Cervero F, Morisson JFB, eds. Progress in Brain Research, Vol. 67. New York : Elsevier, 1986 : 87 144.
27. Kreis ME, Haupt W, Kirkup AJ, Grundy D. Histamine sensitivity of mesenteric afferent nerves in the rat jejunum. Am J Physiol Gastrointest Liver Physiol 1998 275 : G675 80.
28. Hillsley K, Grundy D. Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum. J Physiol 1998 509 : 717 27.
29. Hillsley K, Kirkup AJ, Grundy D. Direct and indirect actions of 5-hydroxytryptamine on the discharge of mesenteric afferent fibres innervating the rat jejunum. J Physiol 1998 506 : 551 61.
30. Liao JK, Homcy CJ. The G proteins of the G alpha i and G alpha q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J Clin Invest 1993 92 : 2168 72.
31. 3 receptors are membrane ion channels. Nature 1989 339 : 706 9.
32. Booth CE, Shaw J, Hicks GA, Kirkup AJ, Winchester W, Grundy D. Influence of the pattern of jejunal distension on mesenteric afferent sensitivity in the anaesthetized rat. Neurogastroenterol Motil 2008 20 : 149 58.
33. Madisch A, Holtmann G, Mayr G, Vinson B, Hotz J. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial. Digestion 2004 69 : 45 52.
34. Madisch A, Melderis H, Mayr G, Sassin I, Hotz J. A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study. Z Gastroenterol 2001 39 : 511 7.
35. Holzer P. Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain. Eur J Pharmacol 2001 429 : 177 93.
36. Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997 112 : 1714 43.
37. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil 2007 19 (Suppl. 2 25 31.
38. Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin N Am 2005 34 : 235 45.
39. Camilleri M. Management of patients with chronic abdominal pain in clinical practice. Neurogstroenterol Motil 2006 18 : 499 506.
40. Tack J, Tailey NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006 160 : 499 506.
41. Gebhart GF. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications IV. Am J Physiol Gastrointest Liver Physiol 2000 278 : 834 8.
42. Drossmann DA, Corazziari E, Tatley NJ, Thompson WG, Whitehead WE (eds). Rome II. The Functional Gastrointestinal Disorders, 2nd edn. Dengon Associates, Mc Lean, VA, USA, 2000.